Alumis Inc. Common Stock
NASDAQ:ALMSBiotechnology
+$0.21 today
- Market cap
- $568.87M
- Beta
- -0.54
- P/E (TTM)
- -12.2
- EPS (TTM)
- -$1.90
Volume 2.01M
Average 1.31M
ALMS Property, Plant & Equipment (Net)
Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.
Alumis Inc. Common StockNASDAQ: ALMS
Property, Plant & Equipment (Net) · Q2 FY2026 · quarter ended Jun 2026
Property, plant & equipment (net) falls 11.5% from a year ago
Property, plant & equipment (net) stood at $34.12M at the end of Q2 FY2026, down 11.5% from a year earlier and up 1.9% from the prior quarter. Over 3 fiscal years it compounded at +98.8% a year.
Context
- Property, plant & equipment (net) amounted to 6.1% of total assets at the end of Q2 FY2026, down 0.2 pp from a year earlier.
- Property, plant & equipment (net) increased in 2 of the last 3 fiscal years.
What to watch
Whether property, plant & equipment (net) keeps falling in the next quarterly balance sheet after a -11.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Property, Plant & Equipment (Net) history
USD · from the balance sheet
- Latest · FY2025
- 35.16M USD
- Year-over-year change
- +4.4%
- 3-year CAGR
- +98.8%
| Period | Period end | Property, Plant & Equipment (Net) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 35.16M | +4.4% |
| FY2024 | 2024-12-31 | 33.69M | -4.4% |
| FY2023 | 2023-12-31 | 35.22M | +687.1% |
| FY2022 | 2022-12-31 | 4.48M | — |
Property, Plant & Equipment (Net) vs competitors
How ALMS compares with its peers on the latest reported figures
- Peers report in different currencies, so property, plant & equipment (net) is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -11.5% is the 4th highest of 9, against a peer median of -18.3%.
- Property, plant & equipment (net) amounts to 6.1% of total assets for ALMS, versus a peer median of 1.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
ALMSAlumis Inc. Common Stock | Jun 2026 | $34.12M USD | -11.5% | +98.8% | 6.1% |
ARTVArtiva Biotherapeutics, Inc. | Mar 2026 | $16.3M USD | -21.6% | -14.3% | 15.4% |
| Mar 2026 | $13.32M USD | -15.0% | -11.4% | 4.0% | |
| Mar 2026 | $2.89M USD | +206.5% | — | 1.5% | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €1.68M EUR | — | — | 1.0% |
| Mar 2026 | €1.07M EUR | +18.3% | -11.2% | 2.2% | |
| Mar 2026 | $785K USD | -43.2% | -30.9% | 0.2% | |
| Dec 2025 | $499K USD | +166.8% | +8.7% | 4.3% | |
| Mar 2026 | $375K USD | -60.5% | -42.4% | 0.4% | |
| Mar 2026 | $209.26K USD | -55.2% | +0.9% | 0.3% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding ALMS) | — | -18.3% | -11.4% | 1.5% | |
Competitors are the stored peer set for ALMS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Alumis Inc. Common Stock
NASDAQ:ALMS
Intrinsic Alpha fair value
Locked
Current Price
$4.40
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.